KLK3 and pachyonychia congenita: With respect to PC heterogeneity, we characterized the metabolic differences between molecular PC subtypes based on the combined Ki67/PSA immunoreactivity score; a useful marker for tumor aggressiveness and providing prognostic information independent to the Gleason and ISUP grading.